Cancer News and Research

Latest Cancer News and Research

Continuing education virtual lecture to help prevent fungal infections in HSCT recipients

Systemic fungal infections are a serious complication of hematopoietic stem cell transplantation (HSCT) and are associated with significant mortality in HSCT recipients. It is critical for healthcare professionals to be aware of the risk factors for fungal infections in HSCT patients and apply optimal strategies for prevention and treatment in this population.

9 Oct 2009

HealthHelp to provide radiation oncology management on national scale

With cancer’s incidence and treatment costs rising, HealthHelp has become the first company to provide radiation oncology management on a national scale. Approximately 4 million Humana patients in 46 states will benefit from this innovative new program.

9 Oct 2009

Number of doses, delivery system and setting impact radiation price tag

When cancer spreads to the bone, radiation treatments can help relieve the pain caused by the tumor. But how best to deliver the radiation may vary widely from one oncologist to the next.

9 Oct 2009

New York Governor participates in roundtable discussion on stem cell research

Albert Einstein College of Medicine of Yeshiva University hosted a roundtable discussion on stem cell research with New York Governor David A. Paterson today. Allen M. Spiegel, M.D., the Marilyn and Stanley M. Katz Dean of Einstein, and eight stem cell researchers discussed advances in medical therapies and treatments that Einstein scientists have been investigating since receiving more than $14 million in State funding for stem cell research.

9 Oct 2009

SCAN members in Maricopa County now have access to three local hospitals

SCAN Health Plan Arizona announced today that Scottsdale Healthcare joined the health plan's provider network, effective immediately.

9 Oct 2009

TargetEx to be the coordinator for CancerGrid consortium

TargetEx llc, Budapest announced today that the Research Directorate General of the Commission of the European Communities approved the transfer of the coordinator responsibilities of the European Cancer Research Consortium (CancerGrid) to TargetEx.

9 Oct 2009

Fight against obesity and heart disease gets new boost from public sector and industry

The battle against obesity, heart disease and other diet related health problems received a -4 Million boost today with the announcement of seven new research projects. The projects, taking place in universities and research institutes across the UK, are part of a partnership between two publicly-funded Research Councils and 15 companies.

9 Oct 2009

NIAID awards $60M for research contracts to discover new adjuvants

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has awarded six new research contracts to discover and characterize novel adjuvants, substances that can be added to vaccines to enhance the protective immune response they induce.

9 Oct 2009

Inclusion of vitamin D values in National Nutrient Database

The next time you run nutritionals using the government's database, you might be pleasantly surprised that some of your favorite foods seem to have received a nutrient boost, virtually overnight.

9 Oct 2009

TGen selected to conduct cancer experiments using advanced computer simulations

SAIC-Frederick Inc., under its prime contract with the National Cancer Institute, has named the Translational Genomics Research Institute (TGen) as one of five national centers selected to conduct cancer experiments using advanced computer simulations.

9 Oct 2009

Plexxikon commences patient dosing in PLX3397 Phase 1 clinical trial

Plexxikon Inc. today announced that dosing of cancer patients with PLX3397 has started in a Phase 1 clinical trial. PLX3397 is a novel, oral investigational drug for treating multiple diseases, including metastatic cancer and rheumatoid arthritis.

9 Oct 2009

NHLBI grants for diagnosis and treatment of cardiovascular and blood disorders

Two teams led by Massachusetts General Hospital (MGH) researchers, also members of the Harvard Stem Cell Institute (HSCI), are among 18 groups receiving National Heart Lung and Blood Institute (NHLBI) grants for the development of stem-cell based tools and treatments to understand and treat cardiovascular and blood disorders.

9 Oct 2009

Cold Spring Publishing releases new oncology publication for nurse practitioners

Cold Spring Publishing, LLC, is pleased to announce The Journal of the Advanced Practitioner in Oncology, a publication for nurse practitioners, clinical nurse specialists, advanced practice nurses, and physician's assistants who practice in the field of oncology.

9 Oct 2009

Manchester scientists test radioimmunotherapy in early phase clinical trials

MANCHESTER SCIENTISTS are testing an emerging therapy called radioimmunotherapy (RIT) in early phase clinical trials, according to a presentation at the NCRI Cancer Conference in Birmingham today (Wednesday).

9 Oct 2009

Study detects hazardous chemicals in health care professionals

Physicians for Social Responsibility (PSR), American Nurses Association (ANA) and Health Care Without Harm (HCWH) released "Hazardous Chemicals In Health Care," the first investigation of chemicals found in bodies of health care professionals.

9 Oct 2009

HST Global announces alliance for R&D of Nutraceutical and Medical Food formulation platform

HST Global, Inc. today announced a strategic R&D alliance with Dr. James W. Forsythe for the research and development of HST’s exclusive Nutraceutical and Medical Food formulation platform.

9 Oct 2009

Burnham Institute officially dedicates its new research facility at Lake Nona

Today, Burnham Institute for Medical Research (Burnham) officially dedicated its new 175,000-square-foot scientific facility and marked the opening of Orlando’s Medical City as a life science center. Burnham at Lake Nona is the research anchor for the new development in southeast Orange County and the east coast campus of the La Jolla, Calif.-based institute.

9 Oct 2009

Researchers identify tool to bolster motivation and improve health behaviors in older adults

Researchers from Boston University School of Medicine (BUSM) have identified a tool, the "Getting-Out-of-Bed (GoB) measure" to assess motivation and life outlook in older adults.

9 Oct 2009

Research study on HPV vaccination efficacy for boys and girls

Persistent infection with high-risk types of human papillomavirus (HPV), a sexually transmitted virus, is known to be a cause of cervical cancer. Current guidelines prioritize HPV vaccination of pre-adolescent girls, which has been shown to be cost-effective in previous studies, but the value of vaccinating boys in the United States has been unclear.

9 Oct 2009

Ipsen signs exclusive marketing agreement to produce and distribute Braintree's BLI-800 for colonic cleansing

Ipsen (Euronext: FR0010259150; IPN), an innovation-driven global specialty pharmaceutical Group and Braintree Laboratories, Inc., a US-based company specializing in the development, manufacturing and marketing of specialty pharmaceuticals, announced today the signature of an agreement for the exclusive manufacturing, marketing and distribution rights of Braintree’s proprietary formulation BLI-800 in colonic cleansing before colonoscopy, the best diagnostic procedure for colorectal cancer screening.

9 Oct 2009